AUTHOR=El-Sheref Essmat M. , Tawfeek Hendawy N. , Hassan Alaa A. , Bräse S. , Elbastawesy Mohammed A. I. , Gomaa Hesham A. M. , Mostafa Yaser A. , Youssif Bahaa G. M. 

TITLE=Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties

JOURNAL=Frontiers in Chemistry

VOLUME=10

YEAR=2022

URL=https://www.frontiersin.org/journals/chemistry/articles/10.3389/fchem.2022.1039176

DOI=10.3389/fchem.2022.1039176

ISSN=2296-2646

ABSTRACT=<p>Novel series of amidines were synthesized <italic>via</italic> the interaction between alicyclic amines, cyclic ketones, and a highly electrophilic 4-azidoquinolin-2(1<italic>H</italic>)-ones without any catalyst or additive. All the obtained products were elucidated based on NMR spectroscopy, mass spectrometry, and elemental analysis. The reaction conditions were optimized using cyclohexanone (2), piperidine (3a), and 4-azido-quinolin-2(1<italic>H</italic>)-one (1a) under an air atmosphere. The new compounds 4a-l and 5a-c were tested for antiproliferative activity against four cancer cell lines using doxorubicin as a reference drug. The most potent derivatives were compounds 4b, 4d, 4e, 4i, and 5c, with GI<sub>50</sub> ranging from 1.00 µM to 1.50 µM. Compound 5c was the most effective derivative against the four cancer cell lines, outperforming doxorubicin. The compounds 4b, 4d, 4e, 4i, and 5c were studied further as topoisomerase I and IIα inhibitors. The compounds tested showed selective inhibition of topo I over topo IIα. Finally, docking studies explain why these compounds prefer topo I over topo IIα.</p>